Stratos Wealth Partners LTD. trimmed its holdings in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 2.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,971 shares of the company’s stock after selling 924 shares during the period. Stratos Wealth Partners LTD.’s holdings in Express Scripts were worth $3,988,000 as of its most recent SEC filing.
A number of other hedge funds have also added to or reduced their stakes in ESRX. Principal Financial Group Inc. boosted its position in Express Scripts by 17.4% in the 1st quarter. Principal Financial Group Inc. now owns 969,252 shares of the company’s stock valued at $66,956,000 after buying an additional 143,479 shares during the last quarter. IFM Investors Pty Ltd boosted its position in Express Scripts by 44.8% in the 2nd quarter. IFM Investors Pty Ltd now owns 25,578 shares of the company’s stock valued at $1,975,000 after buying an additional 7,916 shares during the last quarter. Moon Capital Management LLC bought a new position in Express Scripts in the 2nd quarter valued at $3,653,000. Fisher Asset Management LLC boosted its position in Express Scripts by 3.8% in the 2nd quarter. Fisher Asset Management LLC now owns 416,456 shares of the company’s stock valued at $32,155,000 after buying an additional 15,366 shares during the last quarter. Finally, Hudson Valley Investment Advisors Inc. ADV bought a new position in Express Scripts in the 2nd quarter valued at $1,540,000. 84.20% of the stock is owned by hedge funds and other institutional investors.
A number of brokerages have commented on ESRX. Royal Bank of Canada set a $101.00 price objective on Express Scripts and gave the company a “buy” rating in a research report on Thursday, November 1st. Barclays increased their price objective on Express Scripts from $83.00 to $90.00 and gave the company an “equal weight” rating in a research report on Thursday, November 1st. Maxim Group reiterated a “hold” rating on shares of Express Scripts in a research report on Thursday, November 1st. Leerink Swann set a $100.00 price objective on Express Scripts and gave the company a “hold” rating in a research report on Thursday, November 1st. Finally, William Blair lowered Express Scripts from an “outperform” rating to a “market perform” rating in a research report on Wednesday, October 31st. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Express Scripts presently has an average rating of “Hold” and an average price target of $89.07.
In other news, insider Christine Houston sold 12,898 shares of the firm’s stock in a transaction on Friday, August 10th. The stock was sold at an average price of $85.00, for a total value of $1,096,330.00. Following the transaction, the insider now directly owns 110,908 shares in the company, valued at approximately $9,427,180. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.79% of the stock is owned by company insiders.
NASDAQ:ESRX opened at $97.45 on Tuesday. Express Scripts Holding Co has a 12-month low of $59.17 and a 12-month high of $98.98. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.65 and a current ratio of 0.77. The firm has a market capitalization of $54.55 billion, a PE ratio of 13.73, a P/E/G ratio of 1.22 and a beta of 0.89.
Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.42 by $0.01. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. The business had revenue of $25.56 billion for the quarter, compared to analyst estimates of $25.11 billion. During the same period last year, the company earned $2.51 EPS. The firm’s revenue was up 3.6% on a year-over-year basis. Analysts forecast that Express Scripts Holding Co will post 9.08 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Express Scripts Holding Co (ESRX) Position Trimmed by Stratos Wealth Partners LTD.” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2018/11/06/express-scripts-holding-co-esrx-position-trimmed-by-stratos-wealth-partners-ltd.html.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
See Also: What is the balance sheet?
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.